Müller-Kühnle Julian, Schanz Moritz, Schricker Severin, Benignus Christian, Todoroff Julia, Latus Jörg, Zoller Wolfram, Marschner Dominik
Department of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany.
Robert Bosch Society for Medical Research, Stuttgart, Germany.
PLoS One. 2025 Sep 17;20(9):e0332840. doi: 10.1371/journal.pone.0332840. eCollection 2025.
Renal dysfunction is a frequent and clinically relevant complication of cirrhosis, yet chronic kidney disease (CKD) often remains underrecognized, particularly in non-acute settings. Early identification of at-risk patients is essential to guide timely interventions. Although MELD, Child-Pugh Score (CPS), APRI, and FIB-4 are widely used to assess hepatic disease severity, their predictive value for advanced renal dysfunction is uncertain.
In this retrospective cohort study (2014-2021, Klinikum Stuttgart), we evaluated the ability of MELD, CPS, APRI, and FIB-4 to predict severe renal dysfunction (chronic kidney disease [CKD] stage ≥ 3, according to Kidney Disease: Improving Global Outcomes [KDIGO] classification) in patients with alcoholic cirrhosis. Logistic and linear regression analyses were performed. In addition, machine learning (ML) models were trained to identify non-renal predictors of CKD stage ≥ 3.
Among 131 patients (mean age 62.8 ± 11.3 years; 71% male), 33% met criteria for KDIGO stage ≥ 3. MELD was significantly associated with advanced CKD (OR = 1.379, p < 0.001), with prevalence increasing from 17% (MELD ≤ 9) to 80% (MELD ≥ 20). CPS showed an inverse association (p = 0.002), while APRI and FIB-4 were not predictive. The optimized Random Forest model, refined through ROSE oversampling and feature selection, achieved an AUC of 0.757, with 76% accuracy, 82% sensitivity (KDIGO < 3), and 63% specificity (KDIGO ≥ 3).
MELD was the most reliable conventional score for identifying advanced renal dysfunction in alcoholic cirrhosis. ML-based models incorporating routinely available clinical parameters further improved predictive performance and may support risk stratification in this high-risk population.
肾功能不全是肝硬化常见且具有临床相关性的并发症,但慢性肾脏病(CKD)常常未得到充分认识,尤其是在非急性情况下。早期识别高危患者对于指导及时干预至关重要。尽管终末期肝病模型(MELD)、Child-Pugh评分(CPS)、天冬氨酸氨基转移酶与血小板比值指数(APRI)和FIB-4广泛用于评估肝病严重程度,但其对晚期肾功能不全的预测价值尚不确定。
在这项回顾性队列研究(2014年至2021年,斯图加特临床医院)中,我们评估了MELD、CPS、APRI和FIB-4预测酒精性肝硬化患者严重肾功能不全(根据改善全球肾脏病预后组织[KDIGO]分类,慢性肾脏病[CKD]≥3期)的能力。进行了逻辑回归和线性回归分析。此外,还训练了机器学习(ML)模型以识别CKD≥3期的非肾脏预测因素。
在131例患者(平均年龄62.8±11.3岁;71%为男性)中,33%符合KDIGO≥3期标准。MELD与晚期CKD显著相关(比值比=1.379,p<0.001),患病率从17%(MELD≤9)增至80%(MELD≥20)。CPS呈负相关(p=0.002),而APRI和FIB-4无预测价值。通过ROSE过采样和特征选择优化的随机森林模型的曲线下面积为0.757,准确率为76%,敏感性为82%(KDIGO<3),特异性为63%(KDIGO≥3)。
MELD是识别酒精性肝硬化患者晚期肾功能不全最可靠的传统评分。纳入常规可用临床参数的基于ML的模型进一步提高了预测性能,并可能有助于对该高危人群进行风险分层。